Weekly Summary Alert for Windtree Therapeutics, Inc

Windtreetx sent this email to their subscribers on November 2, 2024.

Windtree Therapeutics, Inc added the following items during the week of October 28, 2024

SEC Filing

News

Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3

WINT	Monday	Tuesday	Wednesday	Thursday	Friday
Opening Price	$0.87	$0.77	$0.79	$0.73	$0.70
Last Trade	$0.87	$0.82	$0.74	$0.70	$0.72
Price Change	+$0.01	-$0.05	-$0.08	-$0.04	+$0.02
Percent Change	+1.16%	-5.75%	-9.76%	-5.41%	+2.86%
Day High	$0.91	$0.83	$0.80	$0.74	$0.74
Day Low	$0.86	$0.73	$0.73	$0.69	$0.69
Volume	1,222,761	976,143	726,946	725,570	396,044

Visit the website →

Text-only version of this email

Windtree Therapeutics, Inc Windtree Therapeutics, Inc added the following items during the week of October 28, 2024 SEC FILING 424B5 8-K NEWS Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3 WINTMondayTuesdayWednesdayThursdayFridayOpening Price$0.87$0.77$0.79$0.73$0.70Last Trade$0.87$0.82$0.74$0.70$0.72Price Change+$0.01-$0.05-$0.08-$0.04+$0.02Percent Change+1.16%-5.75%-9.76%-5.41%+2.86%Day High$0.91$0.83$0.80$0.74$0.74Day Low$0.86$0.73$0.73$0.69$0.69Volume1,222,761976,143726,946725,570396,044 Visit the website →

Show all